The 24 references in paper Alexei Shabunin Vasilevich, Anatoly Karalkin Vasilievich, Dmitry Grekov Nikolaevich, Pavel Drozdov Alexeevich, Алексей Шабунин Васильевич, Анатолий Каралкин Васильевич, Дмитрий Греков Николаевич, Павел Дроздов Алексеевич (2015) “Гибридные технологии в определении функционирующего объема печени перед обширными резекциями // Hybrid Technology in Determining of Functioning Volume Liver Before Major Resection” / spz:neicon:medvis:y:2015:i:4:p:39-45

1
Manfredi S., Lepage C., Hatern C. et al. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg. 2006; 244 (2): 254–259.
(check this in PDF content)
2
Wakao F., Nishimoto H., Katanoda K et al. Cancer Statistics in Japan - 2013. Editorial Board, 2013: 54–55.
(check this in PDF content)
3
Патютко Ю.И., Сагайдак И.В., Поляков А.Н. и др. Комбинированное лечение больных колоректальным раком с метастатическим поражением печени. Журнал им. Н.И. Пирогова. 2008; 7: 20–30.
(check this in PDF content)
4
Liu Z., Zhou Y., Zhang P. et al. Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma. Surg. Laparoscopy Endoscopy & Percutaneous Techniques. 2010; 20 (3): 130–140.
(check this in PDF content)
5
Wu Y.Z., Li B., Wang T. et al. Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. Wld J. Gastroenterol. 2011; 17 (36): 4143–4148.
(check this in PDF content)
6
Wang Y., Luo Q., Li Y. et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials. PloS one. 2014; 9 (1) e84484. doi: 10.1371/journal.pone. 0084484
(check this in PDF content)
7
Zhou Y., Lei X., Wu L. et al. Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: A systematic review. Surg. Oncol. 2014; 23 (4): 236–242.
(check this in PDF content)
8
Aubin F., Blanke C. Pre-operative targeted therapies in patients with hepatic colorectal cancer metastases – bevacizumab versus cetuximab. US Oncol. Rev. 2010; 6 (1): 42–44.
(check this in PDF content)
9
Komori K., Nagino M., Nimura Y. Hepatocyte morphology and kinetics after portal vein embolization. Br. J. Surg. 2006; 93 (6): 745–751.
(check this in PDF content)
10
Lienden K.P., Van den Esschert J.W., de Graaf W. et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc. Interventional Radiol. 2013; 36 (1): 25–34.
(check this in PDF content)
11
Полищук Л.О., Козмин Л.Д., Строяковский Д.Л. и др. Гепатотоксичность химиотерапии колоректального рака: современное состояние проблемы. РЖГГК. 2009; 5: 16–25.
(check this in PDF content)
12
Vauthey J.N., Pawlik T.M., Ribero D. et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 2006; 1; 24 (13): 2065–2072.
(check this in PDF content)
13
Rahbari N.N., Reissfelder C., Koch M. et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann. Surg. Oncol. 2011; 18 (13): 3640–3649.
(check this in PDF content)
14
Colle I., Verhelst X., Vanlander A. et al. Pathophysiology and management of post resection liver failure. Acta Chirur. Belg. 2012; 113 (3): 155–161.
(check this in PDF content)
15
Guglielmi A., Ruzzenente A., Conci S. et al How much remnant is enough in liver resection? Dig. Surg. 2012; 29 (1): 6–17.
(check this in PDF content)
16
Hammond J.S., Guha I.N., Beckingham I.J. et al. Prediction, prevention and management of postresection liver failure. Br. J. Surg. 2011; 98 (9): 1188–1200.
(check this in PDF content)
17
Imamura H., Sano K., Sugawara Y. et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J. Hepato-Biliary-Pancreatic Surg. 2005; 12 (1): 16–22.
(check this in PDF content)
18
Stockmann M., Lock J.F., Malinowski M. et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010; 12 (2): 139–146.
(check this in PDF content)
19
Beppu T., Hayashi H., Okabe H. et al. Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT–computed tomography fusion system. J. Gastroenterol. 2011; 46 (7) 938–943.
(check this in PDF content)
20
Косых Н.Э., Коваленко В.Л., Гостюшкин В.В. и др. К вопросу о применении CAD-систем в ядерной медицине. Научный электронный архив. URL: http://econf.rae. ru/article/7101 (дата обращения 12.05.2015)
(check this in PDF content)
21
Патютко Ю.И., Сагайдак И.В., Котельников А.Г. и др. Резекция печени: современные технологии при опухолевом поражении. Анналы хирургической гепатологии. 2010; 15 (2): 10–17.
(check this in PDF content)
22
Патютко Ю.И., Сагайдак И.В., Чучуев А.Д. и др. Хирургическое лечение первичного рака печени. Практическая онкология. 2008; 9 (4): 197–201.
(check this in PDF content)
23
Nagashima I., Takada T., Okinaga K. et al. A scoring system for the assessment of the risk of mortality after partial hepatectomy in patients with chronic liver dysfunction. J. Hepato-Biliary-Pancreatic Surg. 2005; 12 (1): 44–48.
(check this in PDF content)
24
Yoshida M., Shiraishi S., Sakaquchi F. Fused 99m-Tc-GSA SPECT/CT imading for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve? Jpn. J. Radiol. 2012; 30 (3): 255–262.
(check this in PDF content)